Next Article in Journal
A Selective Dynamic Sampling Back-Propagation Approach for Handling the Two-Class Imbalance Problem
Previous Article in Journal
Adaptive Wavelet Threshold Denoising Method for Machinery Sound Based on Improved Fruit Fly Optimization Algorithm
Article Menu

Export Article

Open AccessArticle
Appl. Sci. 2016, 6(7), 198; doi:10.3390/app6070198

Synthesis of Novel Chalcones as Acetylcholinesterase Inhibitors

1
Department of Medicinal Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, 41 Dinh Tien Hoang St., Dist 1, Ho Chi Minh City 700000, Vietnam
2
Faculty of Applied Sciences, Ton Duc Thang University, 19 Nguyen Huu Tho St., Tan Phong Ward, Dist 7, Ho Chi Minh City 700000, Vietnam
*
Authors to whom correspondence should be addressed.
Received: 18 June 2016 / Accepted: 29 June 2016 / Published: 7 July 2016
(This article belongs to the Section Chemistry)
View Full-Text   |   Download PDF [3581 KB, uploaded 9 July 2016]   |  

Abstract

A new series of benzylaminochalcone derivatives with different substituents on ring B were synthesized and evaluated as inhibitors of acetylcholinesterase. The study is aimed at identification of novel benzylaminochalcones capable of blocking acetylcholinesterase activity for further development of an approach to Alzheimer’s disease treatment. These compounds were produced in moderate to good yields via Claisen-Schmidt condensation and subjected to an in vitro acetylcholinesterase inhibition assay, using Ellman’s method. The in silico docking procedure was also employed to identify molecular interactions between the chalcone compounds and the enzyme. Compounds with ring B bearing pyridin-4-yl, 4-nitrophenyl, 4-chlorophenyl and 3,4-dimethoxyphenyl moieties were discovered to exhibit significant inhibitory activities against acetylcholinesterase, with IC50 values ranging from 23 to 39 µM. The molecular modeling studies are consistent with the hypothesis that benzylaminochalcones could exert their effects as dual-binding-site acetylcholinesterase inhibitors, which might simultaneously enhance cholinergic neurotransmission and inhibit β-amyloid aggregation through binding to both catalytic and peripheral sites of the enzyme. These derivatives could be further developed to provide novel leads for the discovery of new anti-Alzheimer drugs in the future. View Full-Text
Keywords: benzylaminochalcones; Claisen-Schmidt condensation; acetylcholinesterase; Ellman’s method; β-amyloid aggregation; docking benzylaminochalcones; Claisen-Schmidt condensation; acetylcholinesterase; Ellman’s method; β-amyloid aggregation; docking
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Tran, T.-D.; Nguyen, T.-C.-V.; Nguyen, N.-S.; Nguyen, D.-M.; Nguyen, T.-T.-H.; Le, M.-T.; Thai, K.-M. Synthesis of Novel Chalcones as Acetylcholinesterase Inhibitors. Appl. Sci. 2016, 6, 198.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Appl. Sci. EISSN 2076-3417 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top